Artsellens

History

2024: The beginning of the creation of a production complex in Technopolice Moscow

In the special economic zone (SEZ) Technopolice Moscow"" work began on the creation of a research and production complex of the biotechnological company "Artsellens," one of the key investors of which is the biotechnological company Promomed"." The Center for Biotechnology Research and Development (- R&D center) Artsellens will be located at the Technopolice site in Moscow Pechatniki, and the main production will be in, in Alabushevo Zelenograd. Financing of the project is carried out with the support of the city, as well. Sberbank This was announced on May 22, 2024 by the minister, Moscow Government head. Department of Investment and Industrial Policy Vladislav Ovchinsky

The development of medicine and technology related to it is one of the key tasks for the capital industry. So, at two sites of the SEZ "Technopolice Moscow" production and a research center will appear. The city awarded the company the status of a resident of the SEZ, thanks to which the manufacturer will receive a number of tax benefits. The company will be able to direct the saved money to its own development. In addition, an investment loan for the construction was taken thanks to the Moscow Fund for Industry and Entrepreneurship Support, which compensated for part of interest payments. As of May 2024, the design of internal equipment for future facilities is underway, - said Vladislav Ovchinsky.

The project financing provided by Sberbank to Artsellens is 10.5 billion rubles.

Financial support of companies, as well as assistance to the development of domestic pharmaceutical industries is one of the priority areas of our activities. Sberbank provides corporate clients with a large line bank of products and non-financial services at all stages of the implementation of new projects, as well as in the process of financing the current activities of enterprises and organizations. As of May 2024, the loan portfolio of medical and pharmaceutical companies Sberbank Moscow Bank in is more than 76 billion rubles and occupies about 3% of the total loan portfolio of corporate clients of the Moscow Bank, - said the vice president of Sberbank - chairman of the Moscow Bank. Vyacheslav Tsybulnikov

The main activities of Artsellens will be the development and full cycle of the production of biosimilars and innovative biotechnological drugs for the treatment of oncological, autoimmune and other socially significant diseases. At the beginning of 2025, the first stage of the project is planned - the launch of a biotechnological R&D center in Pechatniki. The list of tasks of the center will include the development and pilot production from cell lines to the finished drug of new biotechnological products, the study of the quality of the products obtained, the organization and conduct of preclinical and clinical studies.

As part of the second stage, it is planned to launch a biotechnology plant in Alabushevo. The total capacity of the enterprise is estimated at 150 kilograms of substance per year, or about 750 thousand vials of drugs. Technologies developed at the R&D Center in Pechatniki will be transferred to the production site in Alabushevo. This approach will ensure a full cycle - from idea and development to the production of innovative drugs in the capital.

We are grateful to our partners, the Department of Investment and Industrial Policy of the city of Moscow and Sberbank, for the opportunity to work together on the project. This strategic partnership is a significant step in the development of biotechnology, as one of the areas that contributes to ensuring the drug safety of the country. Artsellens considers solving complex medical problems that require the development and release of its own innovative biotechnological drugs of a new generation to be one of the priorities in its activities, "commented Maxim Smagin, CEO of the company.

A pharmaceutical cluster is being formed in the SEZ "Technopolice Moscow," it includes 11 companies, 8 of which already produce products. Thanks to the support of the city, companies can count on tax breaks, in turn, Moscow receives high-quality goods of local production without delays in deliveries.